⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14931233 | 1.00 | — | — | |
| SCHEMBL10895793 | 0.69 | — | — | |
| SCHEMBL16289054 | 0.68 | — | — | |
| SCHEMBL16673609 | 0.64 | — | — | |
| SCHEMBL766963 | 0.60 | — | — | |
| SCHEMBL910062 | 0.59 | — | — | |
| SCHEMBL18828483 | 0.56 | — | — | |
| SCHEMBL910798 | 0.56 | — | — | |
| SCHEMBL104998 | 0.56 | — | — | |
| SCHEMBL9246880 | 0.50 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 892 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10295907-B2 | Resist underlayer film-forming composition for lithography containing polymer having acrylamide structure and acrylic acid ester structure | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2019-05-21 | — | — | US | claimed |
| US-12044968-B2 | Protective film-forming composition having acetal structure and amide structure | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-23 | — | — | US | disclosed |
| EP-4401115-A1 | METHOD FOR CLEANING SEMICONDUCTOR SUBSTRATE, METHOD FOR MANUFACTURING PROCESSED SEMICONDUCTOR SUBSTRATE, AND COMPOSITION FOR EXFOLIATION AND DISSOLUTION | Nissan Chemical Corporation (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-20240231230-A1 | COMPOSITION FOR FORMING SILICON-CONTAINING RESIST UNDERLAYER FILM | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| EP-4397623-A1 | EPOXY GROUP-CONTAINING ORGANOSILICA SOL, EPOXY RESIN COMPOSITION AND PRODUCTION METHOD THEREOF | Nissan Chemical Corporation (JP) | 2024-07-10 | — | — | EP | disclosed |
| EP-4398285-A1 | ADHESIVE COMPOSITION, MULTILAYER BODY, AND METHOD FOR PRODUCING PROCESSED SEMICONDUCTOR SUBSTRATE | Nissan Chemical Corporation (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-12030974-B2 | Composition for forming block copolymer layer for formation of microphase-separated pattern | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-09 | — | — | US | disclosed |
| US-20240222180-A1 | LAMINATE, METHOD FOR MANUFACTURING LAMINATE, AND METHOD FOR MANUFACTURING SEMICONDUCTOR SUBSTRATE | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-04 | — | — | US | disclosed |
| US-20240218293-A1 | CLEANING AGENT COMPOSITION AND CLEANING METHOD | NISSAN CHEMICAL CORPORATION (JP) | 2024-07-04 | — | — | US | disclosed |
| EP-4393877-A1 | DISPERSION OF SURFACE-TREATED SILICA-CONTAINING INORGANIC OXIDE PARTICLES AND METHOD FOR PRODUCING SAME | Nissan Chemical Corporation (JP) | 2024-07-03 | — | — | EP | disclosed |
| US-5290934-A | Benzoheterocyclic compounds | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1994-03-01 | — | — | US | disclosed |
| EP-0565132-A2 | Benzoheterocyclic compounds | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-10-13 | — | — | EP | disclosed |
| US-4820821-A | ANTIDEPRESSANTS, ANTIHYPOTONIC AGENTS, ANTIPARKINSON DRUGS | BASF AKTIENGESELLSCHAFT (DE) | 1989-04-11 | — | — | US | disclosed |
| CN-1030237-A | BENZOHETEROCYCLIC COMPOUNDS | OTSUKA PHARMA CO LTD (JP) | 1989-01-11 | — | — | CN | disclosed |
| EP-0287951-A2 | 7-Piperazinyl- or 7-Morpholino-4-oxo-quinoline-3-carboxylic acid derivatives, their preparation and their use as antimicrobial agents | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1988-10-26 | — | — | EP | disclosed |
| EP-0078989-B1 | PYRIDAZINONE IMINES AND THEIR PHYSIOLOGICALLY TOLERABLE ADDITION SALTS, PROCESS FOR THEIR PREPARATION AND THERAPEUTICAL AGENTS CONTAINING THOSE COMPOUNDS | BASF Aktiengesellschaft (DE) | 1985-05-08 | — | — | EP | disclosed |
| EP-0042107-B1 | DIHYDROPYRIDAZINONES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS | BASF Aktiengesellschaft (DE) | 1985-04-03 | — | — | EP | disclosed |
| US-4410529-A | HYPOTENSIVE AGNENTS, ANTICOAGULANTS | BASF AKTIENGESELLSCHAFT (DE) | 1983-10-18 | — | — | US | disclosed |
| EP-0078989-A1 | Pyridazinone imines and their physiologically tolerable addition salts, process for their preparation and therapeutical agents containing those compounds | BASF Aktiengesellschaft (DE) | 1983-05-18 | — | — | EP | disclosed |
| EP-0042107-A1 | Dihydropyridazinones, processes for their preparation and pharmaceutical compositions containing these compounds | BASF Aktiengesellschaft (DE) | 1981-12-23 | — | — | EP | disclosed |